6505--Nicotine Lozenges MINI (VA-26-00020754)

The Department of Veterans Affairs National Acquisition Center is seeking to procure Nicotine Polacrilex Mini Lozenges in two strengths (2mg and 4mg), both in 81-count bottles, to establish a supply source for VA and Department of Defense pharmaceutical prime vendors. This is an unrestricted solicitation with small business considerations, using a Standard Form 1449 for commercial products. Key requirements include providing unique NDC/UPC numbers, meeting specific packaging specifications, FDA manufacturing facility compliance, and the ability to distribute through pharmaceutical prime vendors, with a mandatory 0.5% Cost Recovery Fee to be included in pricing. The contract will be awarded to the lowest-price technically acceptable offer based on product specifications, FDA compliance, and distribution capability. The original solicitation closing date of January 14, 2026, at 2:30 PM Central Time has been extended to January 16, 2026, at 2:30 PM CT via Amendment 0002, with offerors required to sign and return a copy of the amendment.

This solicitation carries no set-aside designation and involves a base year plus four one-year option periods. The estimated annual requirements total approximately 166,791 bottles of 2mg lozenges and 138,276 bottles of 4mg lozenges across VA, DoD, Bureau of Prisons, and Indian Health Service combined. The procurement applies NAICS code 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,300 employees and falls under PSC code 6505 (Drugs and Biologicals). While no specific award value is disclosed in the solicitation materials, the volume requirements and multi-year contract structure indicate substantial procurement value. The contract administration will be handled by the Department of Veterans Affairs National Acquisition Center in Hines, Illinois.